pentobarbital decreases amounts of elvitegravir/cobicistat/emtricitabine/tenofovir DF by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. May possibly produce lack of virologic reaction and doable resistance. pentobarbital will minimize the extent or effect of lumacaftor/iv